Michael Hung

Penn Presbyterian Medical Center

Papers

1

Total Citations

8

H-Index

1

About

Dr. Michael Hung is a pioneering urologic oncologist whose work centers on advancing minimally invasive surgical techniques for testicular cancer. His primary research focuses on robotic-assisted retroperitoneal lymph node dissection (R-RPLND), where he has been instrumental in refining operative approaches that significantly reduce patient morbidity compared to traditional open surgery. His most cited paper (2023, 8 citations) provides a comprehensive review of contemporary evidence and details the precise operative technique developed at his center, establishing a benchmark for emerging robotic procedures in this field. Dr. Hung’s contributions have helped shift the standard of care toward less invasive options, improving recovery times and outcomes for testicular cancer patients. His work is widely recognized among urologic surgeons and oncologists, and he continues to shape clinical practice through both his surgical innovations and his role in training the next generation of specialists. With a growing citation impact and a reputation for technical excellence, Dr. Hung stands at the forefront of robotic urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Robotic-assisted retroperitoneal lymph node dissection for testicular cancer
8 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 2
🏛 Institutions: Penn Presbyterian Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago